Neurogene (NASDAQ:NGNE) Now Covered by Analysts at SVB Leerink

SVB Leerink started coverage on shares of Neurogene (NASDAQ:NGNE – Free Report) in a research note published on Monday, Marketbeat reports. The firm issued an outperform rating and a $46.00 price target on the stock. NGNE has been the subject of a number of other research reports. William Blair began coverage on Neurogene in a […]

Related Keywords

William Blair ,Stifel Nicolaus ,Privium Fund Management United Kingdom Ltd ,Great Point Partners ,Capital Management ,Neurogene Inc ,Free Report ,Fund Management United Kingdom Ltd ,Partners Management ,Get Free Report ,Neurogene Daily ,Neurogene ,Nasdaq Ngne ,Engne ,Medical ,Initiated Coverage ,Svb Leerink Llc ,